Cedric Bogaert

Cedric graduated as a Bioscience Engineer at Ghent University, majoring in medical genetics. After his studies, he continued his research on epigenomics by leading a multi-university collaboration on the epigenetic effects of Menohop. A platform for automated dose-response curve analysis was set-up in different breast cancer cell lines, laying the framework for designing personalised nutritional solutions across different indications.

Subsequently, he focused on precision diagnostics and was involved in evaluating different immunotherapy options via the genomic patient profile. While focusing on operational excellence as a pricing architectural lead at Accenture, he joined the Life Sciences Industry Certification Program. During 2018, together with the other co-founders, he officially launched the myNEO technology in a company. Currently, Cedric has taken up the role of acting manager (CEO) of myNEO.